Literature DB >> 12766099

Antihyperglycemic effect of oolong tea in type 2 diabetes.

Kazuaki Hosoda1, Ming-Fu Wang, Mei-Ling Liao, Chin-Kuang Chuang, Miyuki Iha, Beverly Clevidence, Shigeru Yamamoto.   

Abstract

OBJECTIVE: To determine the efficacy of oolong tea for lowering plasma glucose in type 2 diabetic patients in Miaoli, Taiwan. RESEARCH DESIGN AND METHODS: A total of 20 free-living subjects who had type 2 diabetes and took hyperglycemic drugs as prescribed were enrolled in the present study. Subjects consumed oolong tea (1,500 ml) or water for 30 days each in a randomized crossover design. Tea was not consumed for 14 days prior to treatments.
RESULTS: Relative to initial concentrations, oolong tea markedly lowered concentrations of plasma glucose (from 229 +/- 53.9 to 162.2 +/- 29.7 mg/dl, P < 0.001) and fructosamine (from 409.9 +/- 96.1 to 323.3 +/- 56.4 micromol/l, P < 0.01), whereas the water control group had not changed (208.7 +/- 61.0 vs. 232.3 +/- 63.1 mg/dl for glucose and from 368.4 +/- 85.0 to 340.0 +/- 76.1 micromol/l for fructosamine).
CONCLUSIONS: Oolong tea may be an effective adjunct to oral hypoglycemic agents in the treatment of type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766099     DOI: 10.2337/diacare.26.6.1714

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  29 in total

Review 1.  The role of complementary and alternative medicine in diabetes.

Authors:  Shefali Dham; Viral Shah; Sondra Hirsch; Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

2.  Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies.

Authors:  Yali Jing; Guanjun Han; Yun Hu; Yan Bi; Lirong Li; Dalong Zhu
Journal:  J Gen Intern Med       Date:  2009-03-24       Impact factor: 5.128

Review 3.  Tea and human health: biomedical functions of tea active components and current issues.

Authors:  Zong-mao Chen; Zhi Lin
Journal:  J Zhejiang Univ Sci B       Date:  2015-02       Impact factor: 3.066

4.  In vitro antioxidant and pancreatic α-amylase inhibitory activity of isolated fractions from water extract of Qingzhuan tea.

Authors:  Qian Cheng; Shengbao Cai; Dejiang Ni; Ruojun Wang; Feng Zhou; Baoping Ji; Yuqiong Chen
Journal:  J Food Sci Technol       Date:  2013-06-18       Impact factor: 2.701

Review 5.  Tea and cardiovascular disease.

Authors:  Apranta Deka; Joseph A Vita
Journal:  Pharmacol Res       Date:  2011-04-06       Impact factor: 7.658

Review 6.  Complementary and alternative medicine for the treatment of type 2 diabetes.

Authors:  Richard Nahas; Matthew Moher
Journal:  Can Fam Physician       Date:  2009-06       Impact factor: 3.275

7.  The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.

Authors:  Mousumi Bose; Joshua D Lambert; Jihyeung Ju; Kenneth R Reuhl; Sue A Shapses; Chung S Yang
Journal:  J Nutr       Date:  2008-09       Impact factor: 4.798

8.  Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial.

Authors:  A Louise Brown; Joan Lane; Jacqueline Coverly; Janice Stocks; Sarah Jackson; Alison Stephen; Les Bluck; Andy Coward; Hilde Hendrickx
Journal:  Br J Nutr       Date:  2008-08-19       Impact factor: 3.718

Review 9.  Preventive Applications of Polyphenols in Dentistry-A Review.

Authors:  Jasmin Flemming; Clara Theres Meyer-Probst; Karl Speer; Isabelle Kölling-Speer; Christian Hannig; Matthias Hannig
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

10.  Diabetes medications as potential calorie restriction mimetics-a focus on the alpha-glucosidase inhibitor acarbose.

Authors:  Daniel L Smith; Rachael M Orlandella; David B Allison; Lyse A Norian
Journal:  Geroscience       Date:  2020-10-02       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.